DOI QR코드

DOI QR Code

Anti-inflammatory and utero-relaxant effect of α-bisabolol on the pregnant human uterus

  • Munoz-Perez, Victor Manuel (Area Academica de Medicina del Instituto de Ciencias de la Salud. Universidad Autonoma del Estado de Hidalgo) ;
  • Ortiz, Mario I. (Area Academica de Medicina del Instituto de Ciencias de la Salud. Universidad Autonoma del Estado de Hidalgo) ;
  • Ponce-Monter, Hector A. (Area Academica de Medicina del Instituto de Ciencias de la Salud. Universidad Autonoma del Estado de Hidalgo) ;
  • Monter-Perez, Vicente (Hospital General de los SSH) ;
  • Barragan-Ramirez, Guillermo (Hospital General de los SSH)
  • Received : 2017.11.02
  • Accepted : 2018.02.09
  • Published : 2018.07.01

Abstract

The aim of this study was to evaluate the in vitro anti-inflammatory and utero-relaxant effect of ${\alpha}$-bisabolol on the pregnant human myometrium. Samples from the pregnant human myometrium were used in functional tests to evaluate the inhibitory effect of ${\alpha}$-bisabolol (560, 860, 1,200 and $1,860{\mu}M$) on spontaneous myometrial contractions. The intracellular cyclic adenosine monophosphate (cAMP) levels generated in response to ${\alpha}$-bisabolol in human myometrial homogenates were measured by ELISA. The anti-inflammatory effect of ${\alpha}$-bisabolol was determined through the measurement of two pro-inflammatory cytokines, tumor necrosis factor-${\alpha}$ ($TNF{\alpha}$) and interleukin $(IL)-1{\beta}$, and the anti-inflammatory cytokine IL-10, in pregnant human myometrial explants stimulated with lipopolysaccharide (LPS). Forskolin was used as a positive control to evaluate the cAMP and cytokine levels. ${\alpha}$-Bisabolol was found to induce a significant inhibition of spontaneous myometrial contractions at the highest concentration level (p<0.05). ${\alpha}$-Bisabolol caused a concentration-dependent decrease in myometrial cAMP levels (p<0.05) and a concentration-dependent decrease in LPS-induced $TNF{\alpha}$ and $IL-1{\beta}$ production, while IL-10 production did not increase significantly (p>0.05). The anti-inflammatory and utero-relaxant effects induced by ${\alpha}$-bisabolol were not associated with an increase in cAMP levels in pregnant human myometrial samples. These properties place ${\alpha}$-bisabolol as a potentially safe and effective adjuvant agent in cases of preterm birth, an area of pharmacological treatment that requires urgent improvement.

Keywords

References

  1. Kemp MW, Saito M, Newnham JP, Nitsos I, Okamura K, Kallapur SG. Preterm birth, infection, and inflammation advances from the study of animal models. Reprod Sci. 2010;17:619-628. https://doi.org/10.1177/1933719110373148
  2. Burdet J, Rubio AP, Salazar AI, Ribeiro ML, Ibarra C, Franchi AM. Inflammation, infection and preterm birth. Curr Pharm Des. 2014;20:4741-4748. https://doi.org/10.2174/1381612820666140130202224
  3. Munoz-Perez VM, Fernandez-Martinez E, Ponce-Monter H, Ortiz MI. Relaxant and anti-inflammatory effect of two thalidomide analogs as PDE-4 inhibitors in pregnant rat uterus. Korean J Physiol Pharmacol. 2017;21:429-437. https://doi.org/10.4196/kjpp.2017.21.4.429
  4. Hubinont C, Debieve F. Prevention of preterm labour: 2011 update on tocolysis. J Pregnancy. 2011;2011:941057.
  5. de Heus R, Mol BW, Erwich JJ, van Geijn HP, Gyselaers WJ, Hanssens M, Harmark L, van Holsbeke CD, Duvekot JJ, Schobben FF, Wolf H, Visser GH. Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study. BMJ. 2009;338:b744. https://doi.org/10.1136/bmj.b744
  6. Abitayeh G, Tsatsaris V, Goffinet F, Cabrol D. New tocolytic agents. Eur Clinics Obstet Gynecol . 2005;1:29-35. https://doi.org/10.1007/s11296-004-0009-7
  7. Agrawal V, Hirsch E. Intrauterine infection and preterm labor. Semin Fetal Neonatal Med. 2012;17:12-19. https://doi.org/10.1016/j.siny.2011.09.001
  8. Rocha NF, Oliveira GV, Araujo FY, Rios ER, Carvalho AM, Vasconcelos LF, Macedo DS, Soares PM, Sousa DP, Sousa FC. (-)-${\alpha}$-Bisabolol-induced gastroprotection is associated with reduction in lipid peroxidation, superoxide dismutase activity and neutrophil migration. Eur J Pharm Sci. 2011;44:455-461. https://doi.org/10.1016/j.ejps.2011.08.020
  9. de Siqueira RJ, Freire WB, Vasconcelos-Silva AA, Fonseca-Magalhaes PA, Lima FJ, Brito TS, Mourao LT, Ribeiro RA, Lahlou S, Magalhaes PJ. In-vitro characterization of the pharmacological effects induced by (-)-${\alpha}$-bisabolol in rat smooth muscle preparations. Can J Physiol Pharmacol. 2012;90:23-35. https://doi.org/10.1139/y11-094
  10. Ko SG, Yin CS, Du B, Kim KH. Herbal medicines for inflammatory diseases 2016. Mediators Inflamm. 2016;2016:8270323.
  11. Jeon JS, Kim HT, Kim MG, Oh MS, Hong SR, Yoon MH, Shin HC, Shim JH, Afifi NA, Hacimuftuoglu A, El-Aty AMA. Simultaneous detection of glabridin, (-)-${\alpha}$-bisabolol, and ascorbyl tetraisopalmitate in whitening cosmetic creams using HPLC-PAD. Chromatographia. 2016;79:851-860. https://doi.org/10.1007/s10337-016-3104-2
  12. de Siqueira RJ, Ribeiro-Filho HV, Freire RS, Cosker F, Freire WB, Vasconcelos-Silva AA, Soares MA, Lahlou S, Magalhaes PJ. (-)-${\alpha}$-Bisabolol inhibits preferentially electromechanical coupling on rat isolated arteries. Vascul Pharmacol. 2014;63:37-45. https://doi.org/10.1016/j.vph.2014.06.006
  13. Fernandez-Martinez E, Ponce-Monter H, Soria-Jasso LE, Ortiz MI, Arias-Montano JA, Barragan-Ramirez G, Mayen-Garcia C. Inhibition of uterine contractility by thalidomide analogs via phosphodiesterase-4 inhibition and calcium entry blockade. Molecules. 2016;21:E1332. https://doi.org/10.3390/molecules21101332
  14. Oger S, Mehats C, Barnette MS, Ferre F, Cabrol D, Leroy MJ. Antiinflammatory and utero-relaxant effects in human myometrium of new generation phosphodiesterase 4 inhibitors. Biol Reprod. 2004;70:458-464. https://doi.org/10.1095/biolreprod.103.023051
  15. Kinney MV, Lawn JE, Howson CP, Belizan J. 15 Million preterm births annually: what has changed this year? Reprod Health . 2012;9:28. https://doi.org/10.1186/1742-4755-9-28
  16. Purisch SE, Gyamfi-Bannerman C. Epidemiology of preterm birth. Semin Perinatol . 2017;41:387-391. https://doi.org/10.1053/j.semperi.2017.07.009
  17. Rezaeizadeh G, Hantoushzadeh S, Ghiasi S, Nikfar S, Abdollahi M. A systematic review of the uterine relaxant effect of herbal sources. Curr Pharm Biotechnol . 2016;17:934-948. https://doi.org/10.2174/1389201017666160630192037
  18. Tribe RM. Regulation of human myometrial contractility during pregnancy and labour: are calcium homeostatic pathways important? Exp Physiol. 2001;86:247-254. https://doi.org/10.1113/eph8602180
  19. Garfield RE, Maner WL. Physiology and electrical activity of uterine contractions. Semin Cell Dev Biol. 2007;18:289-295. https://doi.org/10.1016/j.semcdb.2007.05.004
  20. Pehlivanoglu B, Bayrak S, Dogan M. A close look at the contraction and relaxation of the myometrium; the role of calcium. J Turk Ger Gynecol Assoc. 2013;14:230-234. https://doi.org/10.5152/jtgga.2013.67763
  21. Luckas MJ, Taggart MJ, Wray S. Intracellular calcium stores and agonist-induced contractions in isolated human myometrium. Am J Obstet Gynecol. 1999;181:468-476. https://doi.org/10.1016/S0002-9378(99)70580-6
  22. Roberts RE, Allen S, Chang AP, Henderson H, Hobson GC, Karania B, Morgan KN, Pek AS, Raghvani K, Shee CY, Shikotra J, Street E, Abbas Z, Ellis K, Heer JK, Alexander SP. Distinct mechanisms of relaxation to bioactive components from chamomile species in porcine isolated blood vessels. Toxicol Appl Pharmacol. 2013;272:797-805. https://doi.org/10.1016/j.taap.2013.06.021
  23. Sassone-Corsi P. The cyclic AMP pathway. Cold Spring Harb Perspect Biol. 2012;4:a011148.
  24. Tasken K, Aandahl EM. Localized effects of cAMP mediated by distinct routes of protein kinase A. Physiol Rev. 2004;84:137-167. https://doi.org/10.1152/physrev.00021.2003
  25. Brenner S, Prosch S, Schenke-Layland K, Riese U, Gausmann U, Platzer C. cAMP-induced Interleukin-10 promoter activation depends on CCAAT/enhancer-binding protein expression and monocytic differentiation. J Biol Chem. 2003;278:5597-5604. https://doi.org/10.1074/jbc.M207448200
  26. Insel PA, Ostrom RS. Forskolin as a tool for examining adenylyl cyclase expression, regulation, and G protein signaling. Cell Mol Neurobiol. 2003;23:305-314. https://doi.org/10.1023/A:1023684503883
  27. Choi YH, Kim GY, Lee HH. Anti-inflammatory effects of cordycepin in lipopolysaccharide-stimulated RAW 264.7 macrophages through Toll-like receptor 4-mediated suppression of mitogenactivated protein kinases and $NF-{\kappa}B$ signaling pathways. Drug Des Devel Ther. 2014;8:1941-1953.
  28. Cha JY, Jung JY, Jung JY, Lee JR, Cho IJ, Ku SK, Byun SH, Ahn YT, Lee CW, Kim SC, An WG. Inhibitory effects of traditional herbal formula pyungwi-san on inflammatory response in vitro and in vivo. Evid Based Complement Alternat Med. 2013;2013:630198.
  29. Gomez-Lopez N, StLouis D, Lehr MA, Sanchez-Rodriguez EN, Arenas-Hernandez M. Immune cells in term and preterm labor. Cell Mol Immunol . 2014;11:571-581. https://doi.org/10.1038/cmi.2014.46
  30. Jantan I, Ahmad W, Bukhari SN. Plant-derived immunomodulators: an insight on their preclinical evaluation and clinical trials. Front Plant Sci . 2015;6:655.
  31. Kiemer AK, Muller C, Vollmar AM. Inhibition of LPS-induced nitric oxide and TNF-alpha production by alpha-lipoic acid in rat Kupffer cells and in RAW 264.7 murine macrophages. Immunol Cell Biol. 2002;80:550-557. https://doi.org/10.1046/j.1440-1711.2002.01124.x
  32. Saad B, Abouatta BS, Basha W, Hmade A, Kmail A, Khasib S, Said O. Hypericum triquetrifolium-derived factors downregulate the production levels of LPS-induced nitric oxide and tumor necrosis factor-${\alpha}$ in THP-1 cells. Evid Based Complement Alternat Med. 2011;2011:586470.
  33. Iyer SS, Cheng G. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol. 2012;32:23-63. https://doi.org/10.1615/CritRevImmunol.v32.i1.30
  34. Saraiva M, O'Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol. 2010;10:170-181. https://doi.org/10.1038/nri2711
  35. Kelly A, Lynch A, Vereker E, Nolan Y, Queenan P, Whittaker E, O'Neill LA, Lynch MA. The anti-inflammatory cytokine, interleukin (IL)-10, blocks the inhibitory effect of IL-1 beta on long term potentiation. A role for JNK. J Biol Chem. 2001;276:45564-45572. https://doi.org/10.1074/jbc.M108757200
  36. Oger S, Mehats C, Dallot E, Ferre F, Leroy MJ. Interleukin-1beta induces phosphodiesterase 4B2 expression in human myometrial cells through a prostaglandin E2- and cyclic adenosine 3',5'-monophosphate-dependent pathway. J Clin Endocrinol Metab. 2002;87:5524-5531. https://doi.org/10.1210/jc.2002-020575
  37. D'Almeida APL, Pacheco de Oliveira MT, de Souza ET, de Sa Coutinho D, Ciambarella BT, Gomes CR, Terroso T, Guterres SS, Pohlmann AR, Silva PM, Martins MA, Bernardi A. ${\alpha}$-Bisabololloaded lipid-core nanocapsules reduce lipopolysaccharide-induced pulmonary inflammation in mice. Int J Nanomedicine. 2017;12:4479-4491. https://doi.org/10.2147/IJN.S130798
  38. Roh E, Yun CY, Young Yun J, Park D, Doo Kim N, Yeon Hwang B, Jung SH, Park SK, Kim YB, Han SB, Kim Y. cAMP-binding site of PKA as a molecular target of bisabolangelone against melanocytespecific hyperpigmented disorder. J Invest Dermatol. 2013;133:1072-1079. https://doi.org/10.1038/jid.2012.425
  39. Kim S, Lee J, Jung E, Huh S, Park JO, Lee JW, Byun SY, Park D. Mechanisms of depigmentation by alpha-bisabolol. J Dermatol Sci. 2008;52:219-222. https://doi.org/10.1016/j.jdermsci.2008.06.005
  40. Avni D, Ernst O, Philosoph A, Zor T. Role of CREB in modulation of TNFalpha and IL-10 expression in LPS-stimulated RAW264.7 macrophages. Mol Immunol. 2010;47:1396-1403. https://doi.org/10.1016/j.molimm.2010.02.015
  41. Wen AY, Sakamoto KM, Miller LS. The role of the transcription factor CREB in immune function. J Immunol. 2010;185:6413-6419. https://doi.org/10.4049/jimmunol.1001829
  42. Shima E, Katsube M, Kato T, Kitagawa M, Hato F, Hino M, Takahashi T, Fujita H, Kitagawa S. Calcium channel blockers suppress cytokine-induced activation of human neutrophils. Am J Hypertens. 2008;21:78-84. https://doi.org/10.1038/ajh.2007.13
  43. Barreto RSS, Quintans JSS, Amarante RKL, Nascimento TS, Amarante RS, Barreto AS, Pereira EWM, Duarte MC, Coutinho HDM, Menezes IRA, Zengin G, Aktumsek A, Quintans-Junior LJ. Evidence for the involvement of $TNF-{\alpha}$ and IL-$1{\beta}$ in the antinociceptive and anti-inflammatory activity of Stachys lavandulifolia Vahl. (Lamiaceae) essential oil and (-)-${\alpha}$-bisabolol, its main compound, in mice. J Ethnopharmacol. 2016;191:9-18. https://doi.org/10.1016/j.jep.2016.06.022
  44. Marongiu L, Donini M, Bovi M, Perduca M, Vivian F, Romeo A, Mariotto S, Monaco HL, Dusi S. The inclusion into PLGA nanoparticles enables ${\alpha}$-bisabolol to efficiently inhibit the human dendritic cell pro-inflammatory activity. J Nanopart Res. 2014;16:2554. https://doi.org/10.1007/s11051-014-2554-4
  45. Corpas-Lopez V, Morillas-Marquez F, Navarro-Moll MC, Merino- Espinosa G, Diaz-Saez V, Martin-Sanchez J. (-)-${\alpha}$-Bisabolol, a promising oral compound for the treatment of visceral leishmaniasis. J Nat Prod. 2015;78:1202-1207. https://doi.org/10.1021/np5008697
  46. Andersen FA. Final report on the safety assessment of Bisabolol. Int J Toxicol. 1999;18(3 suppl):33-40. https://doi.org/10.1177/109158189901800305

Cited by

  1. Preterm Birth, Inflammation and Infection: New Alternative Strategies for their Prevention vol.20, pp.5, 2018, https://doi.org/10.2174/1389201020666190408112013
  2. Tocolytic effect of the monoterpenic phenol isomer, carvacrol, on the pregnant rat uterus vol.63, pp.5, 2018, https://doi.org/10.4103/cjp.cjp_56_20
  3. In vitro effects of citral on the human myometrium: Potential adjunct therapy to prevent preterm births vol.113, pp.8, 2018, https://doi.org/10.1002/bdr2.1873
  4. Role of the NO-cGMP-K+ channels pathway in the peripheral antinociception induced by α-bisabolol vol.99, pp.10, 2018, https://doi.org/10.1139/cjpp-2020-0744